Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Simón Cárdenas Robledo"'
Autor:
Simón Cárdenas Robledo, Laura Estefanía Arenas-Vargas, Diego Armando Guerrero-Gómez, René Carvajal-Junco, Claudia Guío-Sánchez
Publikováno v:
Acta Neurológica Colombiana, Vol 39, Iss 4 (2023)
Introducción: la enfermedad asociada a anticuerpos contra la glicoproteína de mielina del oligodendrocito (MOGAD, por sus siglas en inglés) es una entidad clínica recientemente identificada. La frecuencia de presentación del MOGAD es desconocida
Externí odkaz:
https://doaj.org/article/d5be124a8eba4404baaaf69612f64cf9
Autor:
Simón Cárdenas-Robledo, Laura Estefanía Arenas-Vargas, Rubén Darío Arenas, Jorge Mario Gaspar-Toro, Ángela María Muñoz-Rosero, Aranza Helena Tafur-Borrero, Daniel Stiven Marín-Medina, Hernan Andrés Acosta-Fajardo, Claudia Guío-Sánchez, Lorena López-Reyes
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Effective interventions for Multiple Sclerosis require timely treatment optimization which usually involves switching disease modifying therapies. The patterns of prescription and the reasons for changing treatment in people with
Externí odkaz:
https://doaj.org/article/224e7530d5a14664a311fb41827a1241
Autor:
Nevin John, Steve Vucic, Riadh Gouider, Tomas Kalincik, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Serkan Ozakbas, Jeannette Lechner-Scott, Cavit Boz, Julie Prevost, Recai Turkoglu, Vincent Van Pesch, Cristina Ramo-Tello, Mark Slee, Raed Alroughani, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Suzanne Hodgkinson, Rana Karabudak, Tim Spelman, Helmut Butzkueven, Noriko Isobe, Paul G Sanfilippo, Michael Barnett, Orla Gray, Maria José Sá, Allan Kermode, Guy Laureys, Richard Macdonell, Anneke Van Der Walt, Ayse Altintas, Mario Habek, Pamela McCombe, Seyed Mohammad Baghbanian, Yi Chao Foong, Riki Matsumoto, Abdullah Al-Asmi, Bruce Taylor, Samia J Khoury, Todd Hardy, Katherine Buzzard, Marzena Fabis-Pedrini, Louise Rath, Olga Skibina, Jiwon Oh, William M Carroll, Katrin Gross-Paju, Jan Schepel, Sara Eichau, Elisabetta Cartechini, Aysun Soysal, Davide Maimone, Anoushka Lal, Masoud Etemadifar, Oliver Gerlach, Saloua Mrabet, Emanuele D'Amico, Yolanda Blanco, Matteo Foschi, Melissa Cambron, Andrea Surcinelli, David Levitz, Liesbeth Van Hijfte, Mehmet Fatih Yetkin, Simón Cárdenas-Robledo, Emmanuelle Lapointe, Abdorreza Naser Moghadasi, Gregor Brecl Jakob, Talal Al-Harbi
Publikováno v:
BMJ Neurology Open, Vol 6, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/fc8e0655ceeb42e4b6966e9c79930d0b
Autor:
Simón Cárdenas-Robledo, Laura Estefanía Arenas-Vargas, Rubén Darío Arenas, Jorge Mario Gaspar-Toro, Ángela María Muñoz-Rosero, Aranza Helena Tafur-Borrero, Daniel Stiven Marín-Medina, Hernan Andrés Acosta-Fajardo, Claudia Guío-Sánchez, Lorena López-Reyes
Effective interventions for treating multiple sclerosis (MS) require prompt treatment optimization which usually involves switching disease modifying drugs (DMDs). The patterns of prescription and the reasons treatment changes, especially in low prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa3f536e5c9b3b656a33e2e541a52551
https://doi.org/10.21203/rs.3.rs-2697814/v1
https://doi.org/10.21203/rs.3.rs-2697814/v1
Autor:
Alvaro Cobo-Calvo, Ana Zabalza, Jordi Río, Georgina Arrambide, Susana Otero-Romero, Paula Tagliani, Simón Cárdenas-Robledo, Mireia Castillo, Carmen Espejo, Marta Rodriguez, Pere Carbonell, Breogán Rodríguez, Luciana Midaglia, Ángela Vidal-Jordana, Carmen Tur, Ingrid Galan, Joaquín Castillo, Manuel Comabella, Carlos Nos, Cristina Auger, Mar Tintoré, Àlex Rovira, Xavier Montalban, Jaume Sastre-Garriga
Publikováno v:
Journal of Neurology
Introduction To evaluate the impact of the COVID-19 pandemic on (1) number of clinical visits, (2) magnetic resonance (MR) scans, and (3) treatment prescriptions in a multiple sclerosis (MS) referral centre. Methods Retrospective study covering Janua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a71424776c5f8336537335278d93d7b5
https://doi.org/10.1007/s00415-021-10958-z
https://doi.org/10.1007/s00415-021-10958-z
Publikováno v:
Frontiers in Neurology. 13
BackgroundMost women with multiple sclerosis (MS) have childbearing potential. Although fertility and pregnancy are not affected by MS, the fertility preferences of women with MS can change due to the risk of complications for the mother and/or adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac36ae82ce0f2aaff4ca83fda664a6ea
https://doi.org/10.3389/fneur.2022.1035596
https://doi.org/10.3389/fneur.2022.1035596
Publikováno v:
Multiple Sclerosis and Related Disorders. 67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e7ef0d297807d880df7f9c7f95cfa7e
https://doi.org/10.1016/j.msard.2022.103953
https://doi.org/10.1016/j.msard.2022.103953
Autor:
Simón Cárdenas-Robledo, Paula González-Caicedo, Michael Steven Carvajal-Parra, Claudia Marcela Guío-Sánchez, Lorena López-Reyes
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England).
Background: Multiple sclerosis risk has been shown to have seasonal variations that are more pronounced in higher latitudes. However, this phenomenon has not been adequately studied near the Equator. Objective: To explore the risk of multiple scleros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52eb1e4b53efca8517abd9806840333
https://pubmed.ncbi.nlm.nih.gov/36250508
https://pubmed.ncbi.nlm.nih.gov/36250508
Autor:
Mar Tintoré, Simón Cárdenas-Robledo, Maria Angels Passarell-Bacardit, Susana Otero-Romero, Pere Carbonell-Mirabent, Xavier Montalban, Jaume Sastre-Garriga
Publikováno v:
European Journal of Neurology. 28:4124-4134
BACKGROUND AND PURPOSE Comorbidities are common in multiple sclerosis (MS), and have been associated with worse outcomes and increased health care resource usage. We studied the frequency of comorbidities and adverse health behaviors (AHBs) in MS pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d127a1f3ccde49e01d31c602087178ab
https://doi.org/10.1111/ene.15030
https://doi.org/10.1111/ene.15030
Autor:
Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, Agustín Pappolla, Paula Tagliani, Samuel López-Maza, Simón Cárdenas-Robledo, Juliana Esperalba, Candela Fernández-Naval, Monica Martínez-Gallo, Mireia Castillo, Mercè Bonastre, Mireia Resina-Salles, Jordina Bertran, Marta Rodriguez-Barranco, Pere Carbonell-Mirabent, Marina Gonzalez, Miguel Merchan, Ana Quiroga-Varela, Albert Miguela, Imma Gómez, Gary Álvarez, René Robles, Dúnia Perez del Campo, Xavier Queralt, Maria José Soler, Irene Agraz, Fernando Martinez-Valle, Breogán Rodríguez-Acevedo, Luciana Midaglia, Ángela Vidal-Jordana, Álvaro Cobo-Calvo, Carmen Tur, Ingrid Galan, Joaquín Castillo, Jordi Río, Carmen Espejo, Manuel Comabella, Carlos Nos, Jaume Sastre-Garriga, Lluís Ramió-Torrentà, Mar Tintoré, Xavier Montalban
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 28(7)
Background: The effect of disease-modifying therapies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response is unclear. Objectives: We aim to determine the immunological responses to SARS-CoV-2 in multiple sclerosis (MS) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b98b3d06c743d1ece8e40e4f5a19bd4
https://pubmed.ncbi.nlm.nih.gov/35475363
https://pubmed.ncbi.nlm.nih.gov/35475363